Sabin's research on Dengue was mentioned in a New York Times article.
Novartis today announced that it has entered into a development and licensing agreement with Biological E Limited (BioE), a biopharmaceutical company based in India, for two vaccines to protect against typhoid and paratyphoid fevers. The agreement advances the Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions.
The Proceedings of the 10th International Rotavirus Sympoisum can be accessed by clicking the link above (best viewed with Internet Explorer).
Printed copies can be obtained on request by emailing firstname.lastname@example.org